Probability assessment of photoneutron production of Varian-Clinac ix linear accelerator using Monte Carlo simulation

Document Type : Short/Technical paper


1 Department of Physics and Energy Engineering, School of Sciences, Amirkabir University of Technolog , Tehran, Iran

2 Faculty of Engineering, Science and Research Branch, Islamic Azad University, Tehran, Iran

3 Nuclear Science and Technology Research Institute (NSTRI), Tehran, Iran



Overdose in the patient's body disrupts the treatment process and may have devastating effects. On the other hand, if the particle is a neutron, this effect would be multiplied. Because neutrons in the energy range of about 0.1 to 2 MeV produced in medical linear accelerators have a Quality Factor (QA) of 20, which creates a high equivalent dose in the tissue. In this paper, the photoneutron production probability of components of the 18 MV Varian-Clinac ix linear accelerator has been performed using the Monte Carlo simulation. The contribution of each gantry component of the accelerator and phantom in neutron production per gray of photons was calculated. Results showed that the largest ratio in the production of photoneutrons belongs to the primary collimator per photon gray per square centimetre. Also, in the target, which is the first source of photon neutron production, the flux of thermal neutrons is calculated at zero.


Main Subjects

  1. Yani, R. Tursinah, M. F. Rhani, R. C. X. Soh, F. Haryanto, and I. Arif, "Neutron contamination of Varian Clinac iX 10 MV photon beam using Monte Carlo simulation," Journal of Physics: Conference Series, vol. 694, no. 1, p. 012020, 2016/03/01 2016, doi:
  2. E. Citrin, "Recent Developments in Radiotherapy," New England Journal of Medicine, vol. 377, no. 11, pp. 1065-1075, 2017, doi:
  3. Schaue and W. H. McBride, "Opportunities and challenges of radiotherapy for treating cancer," (in eng), Nat Rev Clin Oncol, vol. 12, no. 9, pp. 527-540, Sep 2015, doi:
  4. Yamamoto et al., "Tumour and immune cell dynamics explain the PSA bounce after prostate cancer brachytherapy," (in eng), Br J Cancer, vol. 115, no. 2, pp. 195-202, Jul 12 2016, doi:
  5. Kaiserman, I. Anteby, I. Chowers, E. Z. Blumenthal, I. Kliers, and J. Pe’er, "Post-brachytherapy initial tumour regression rate correlates with metastatic spread in posterior uveal melanoma," British Journal of Ophthalmology, vol. 88, no. 7, pp. 892-895, 2004, doi:
  6. Veronesi et al., "Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial," The Lancet Oncology, vol. 14, no. 13, pp. 1269-1277, 2013, doi:
  7. Abel et al., "Impact on quality of life of IMRT versus 3-D conformal radiation therapy in head and neck cancer patients: A case control study," Advances in Radiation Oncology, vol. 2, no. 3, pp. 346-353, 2017/07/01/ 2017, doi:
  8. Chun et al., "Comparison of 3-D conformal and intensity modulated radiation therapy outcomes for locally advanced non-small cell lung cancer in NRG Oncology/RTOG 0617," International Journal of Radiation Oncology, Biology, Physics, vol. 93, no. 3, pp. S1-S2, 2015, doi:
  9. Krishnan, "Development of electron linear accelerators in SAMEER," in Proceedings of the seventh DAE-BRNS Indian particle accelerator conference: book of abstracts, 2015. [Online]. Available:
  10. Wideröe, "Über ein neues Prinzip zur Herstellung hoher Spannungen," Arbeiten aus dem Elektrotechnischen Institut der Technischen Hochschule Aachen: Band III: 1928, pp. 157-176, 1929, doi:
  11. Juntong, R. Chimchang, S. Rimjaem, and C. Saisa-ard, "Design of Electron Gun and S-Band Structure for Medical Electron Linear Accelerator," in 7th Int. Particle Accelerator Conf.(IPAC'16), Busan, Korea, May 8-13, 2016, 2016: JACOW, Geneva, Switzerland, pp. 1930-1932. [Online]. Available:
  12. I. Thwaites and J. B. Tuohy, "Back to the future: the history and development of the clinical linear accelerator," Physics in Medicine & Biology, vol. 51, no. 13, p. R343, 2006/06/20 2006, doi:
  13. T. Cooper, R. E. Vatner, and H. A. Shih, "Brain Irradiation Paradigms for Childhood Central Nervous System Tumors," Pituitary Disorders of Childhood: Diagnosis and Clinical Management, pp. 299-320, 2019, doi:
  14. Hoffman, E. Chung, C. Hess, R. Stern, and S. Benedict, "Characterization and evaluation of an integrated quality monitoring system for online quality assurance of external beam radiation therapy," Journal of Applied Clinical Medical Physics, vol. 18, no. 1, pp. 40-48, 2017, doi:
  15. J. Murray and J. Lilley, "Radiotherapy: technical aspects," Medicine, vol. 48, no. 2, pp. 79-83, 2020/02/01/ 2020, doi:
  16. “Varian Medical Systems, Inc, Varian Medical Systems Introduces Clinac iX™ Line of High-Performance Linear Accelerators for Treating Cancer,” Oncology, October 2004, [Online], Available:  
  17. Chen et al., "Measurements and comparisons for data of small beams of linear accelerators," Chinese journal of cancer, vol. 28, no. 3, pp. 272-276, 2009. [Online]. Available:
  18. K. Agarwal, R. V. SCHEELE, and J. WAKLEY, "Tissue maximum-dose ratio (Tmr) for 8 MV X rays," American Journal of Roentgenology, vol. 112, no. 4, pp. 797-802, 1971, doi:
  19. Ashrafinia, A. Hadadi, D. Sardari, and E. Saeedzadeh, "Investigation of LINAC structural effects on photoneutron specified parameters using FLUKA code," Iranian Journal of Medical Physics, vol. 17, no. 1, pp. 7-14, 2020, doi:
  20. Ma, J. Awotwi-Pratt, A. Alghamdi, A. Alfuraih, and N. Spyrou, "Monte Carlo study of photoneutron production in the Varian Clinac 2100C linac," Journal of Radioanalytical and Nuclear Chemistry, vol. 276, no. 1, pp. 119-123, 2008, doi:
  21. Bednarz and X. G. Xu, "Monte Carlo modeling of a 6 and 18 MV Varian Clinac medical accelerator for in-field and out-of-field dose calculations: development and validation," Physics in Medicine & Biology, vol. 54, no. 4, p. N43, 2009, doi:
  22. Hedin, A. Bäck, J. Swanpalmer, and R. Chakarova, "Monte Carlo simulation of linear accelerator Varian Clinac iX," Report MFT-Radfys, vol. 1, 2010. [Online]. Available:
  23. Hachemi and S. Khoudri, "PENELOPE simulations and experiment for 6 MV clinac iX accelerator for standard and small static fields," Applied Radiation and Isotopes, vol. 174, p. 109749, 2021, doi:
  24. Assalmi and N. Mansour, "Validation of Monte carlo Geant4 multithreading code for a 6 MV photon beam of varian linac on the grid computing," Reports of Practical Oncology and Radiotherapy, vol. 25, no. 6, pp. 1001-1010, 2020, doi:
  25. Yamamoto, K. Yamada, T. Yabe, Y. Hirano, and J. Kataoka, "Dose distribution measurements using luminol water during irradiation of high-energy X-rays from medical linear accelerators (LINAC)," Radiation Physics and Chemistry, vol. 208, p. 110895, 2023, doi:
  26. B. Pelowitz, "MCNPXTM user’s manual," Los Alamos National Laboratory, Los Alamos, vol. 5, p. 369, 2005. [Online]. Available:
  27. Liu, X. Lv, W. Zhao, K. Wang, J. Tu, and X. Ouyang, "The comparison of MCNP perturbation technique with MCNP difference method in critical calculation," Nuclear engineering and design, vol. 240, no. 8, pp. 2005-2010, 2010, doi:
  28. Wang, C. Esquivel, E. Nes, C. Shi, N. Papanikolaou, and M. Charlton, "The neutron dose equivalent evaluation and shielding at the maze entrance of a Varian Clinac 23EX treatment room," Medical physics, vol. 38, no. 3, pp. 1141-1149, 2011, doi:
  29. Khan, F.M. and J.P. Gibbons, Khan's the physics of radiation therapy, Journal of medical physics, 2014: Lippincott Williams & Wilkins, DOI:
  30. A. Nedaie et al., "Neutron dose measurements of Varian and Elekta linacs by TLD600 and TLD700 dosimeters and comparison with MCNP calculations," Journal of Medical Physics, vol. 39, no. 1, pp. 10-17, 2014, doi:
  31. Yücel, İ. Çobanbaş, A. Kolbaşı, A. Ö. Yüksel, and V. Kaya, "Measurement of photo-neutron dose from an 18-MV medical linac using a foil activation method in view of radiation protection of patients," Nuclear engineering and technology, vol. 48, no. 2, pp. 525-532, 2016, doi: